Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03837457
Title PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM)
Acronym PRISM
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors miRagen Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA | FRA | BEL

No variant requirements are available.